Non-canonical functions of Cas9 andthe cell biology of CRISPR-Cas immunity
Cas9的非典型功能和CRISPR-Cas免疫的细胞生物学
基本信息
- 批准号:10458754
- 负责人:
- 金额:$ 40.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Antibiotic ResistanceAutoimmunityBacteriaBacterial ChromosomesBacterial GenesBacteriophagesBiologyCRISPR/Cas technologyCellsCellular biologyClustered Regularly Interspaced Short Palindromic RepeatsDevelopmentEnvironmentEquilibriumEventFoundationsFunctional disorderGenerationsGenesGeneticGenetic DiseasesGenetic TranscriptionGuide RNAHeterogeneityHorizontal Gene TransferImmunityImmunizationInfectionLaboratory StudyMemoryPhysiologyPlasmidsPopulationRegulationRepressionResearch DesignRoleRouteStreptococcus pyogenesStressSystemTechnologyTimeToxinTranscription Repressoradaptive immunitycommensal bacteriadrug resistant pathogengenetic elementhuman pathogenimaging platforminnovationinsightnovelnucleasepathogenic bacteriapreventpromoterresistance genespatiotemporaltool
项目摘要
SUMMARY
CRISPR-Cas loci provide bacteria with adaptive immunity against phages and plasmids. By
remembering and destroying foreign genetic elements, CRISPR-Cas systems also restrict
horizontal gene transfer, a frequent route for the dissemination of antibiotic resistance genes
and toxins. To balance defense with genetic exchange, CRISPR-Cas systems likely undergo
spatiotemporal regulation; however, little is known about the ways in which CRISPR-Cas loci
interact with their bacterial hosts or changing environments.
My laboratory studies type II CRISPR-Cas systems, which encode the gene-editing tool cas9.
CRISPR-Cas9 systems are frequently found in human pathogens like S. pyogenes, and we are
focused on understanding how CRISPR-Cas9 activities are intertwined with and often defined
by the biology of their bacterial host cell. We recently discovered that S. pyogenes Cas9
performs a novel autoregulatory function. A non-canonical guide RNA repurposes Cas9 from a
nuclease into a transcriptional repressor that silences its own promoter. This finding helps
explain how CRISPR-Cas9 systems prevent autoimmunity against the bacterial chromosome,
but it remains unclear how CRISPR-Cas expression can be induced as needed, for instance
during or preceding a phage infection.
In this proposal, we explore two new directions in CRISPR-Cas biology. First, we investigate the
non-canonical regulatory roles of Cas9. Specifically, we characterize the conditions and
mechanisms that allow Cas9 to transiently relieve its repression and induce CRISPR-Cas
expression, and we ask whether Cas9 evolved to regulate other bacterial genes outside the
CRISPR-Cas locus. These studies will establish a new foundation for understanding the role of
Cas9 in the physiology of commensal and pathogenic bacteria. Furthermore, our studies on
non-canonical guide RNAs will lead to new strategies for the development of controllable Cas9
technologies and therapies. In our second project, we establish an innovative imaging platform
to observe live CRISPR-Cas immunization events for the first time. This project will illuminate a
fundamental unanswered question in CRISPR-Cas biology: why are new memories successfully
formed in only one in a million infected cells? The answers will provide new clues into the ways
in which heterogeneity within bacterial populations enables survival. Furthermore, these insights
and tools will be valuable for the development of phage therapies, which are offering promise in
combatting the growing threat of antibiotic-resistant pathogens.
总结
CRISPR-Cas基因座为细菌提供针对质粒和质粒的适应性免疫。通过
CRISPR-Cas系统还可以记住和破坏外来遗传元件,
水平基因转移是抗生素耐药基因传播的常见途径
和毒素。为了平衡防御与基因交换,CRISPR-Cas系统可能会经历
时空调控;然而,关于CRISPR-Cas基因座
与细菌宿主相互作用或改变环境。
我的实验室研究II型CRISPR-Cas系统,该系统编码基因编辑工具cas9。
CRISPR-Cas9系统经常在人类病原体中发现,如S.化脓菌,我们是
专注于了解CRISPR-Cas9活动是如何与CRISPR-Cas9活动交织在一起的,
由细菌宿主细胞的生物学决定。我们最近发现S.链球菌Cas9
执行新的自动调节功能。一种非经典的指导RNA从一种非经典的指导RNA中重新利用Cas9。
将核酸酶转化为使其自身启动子沉默的转录阻遏物。这一发现有助于
解释CRISPR-Cas9系统如何防止针对细菌染色体的自身免疫,
但目前还不清楚CRISPR-Cas表达如何根据需要被诱导,
在噬菌体感染期间或之前。
在这项提案中,我们探索了CRISPR-Cas生物学的两个新方向。首先,我们调查
Cas9的非经典调节作用。具体来说,我们描述了条件和
允许Cas9暂时解除其抑制并诱导CRISPR-Cas的机制
表达,我们问Cas9是否进化到调节其他细菌基因以外的基因。
CRISPR-Cas基因座。这些研究将为理解
Cas9在肠道和病原菌生理学中的作用。此外,我们的研究
非典型的指导RNA将导致开发可控Cas9的新策略
技术和疗法。在我们的第二个项目中,我们建立了一个创新的成像平台
首次观察到活的CRISPR-Cas免疫事件。该项目将照亮一个
CRISPR-Cas生物学中一个基本的未解答的问题:为什么新记忆能成功地
百万分之一的感染细胞中形成的答案将提供新的线索,
其中细菌群体内的异质性使其能够存活。此外,这些见解
和工具将是有价值的噬菌体疗法的发展,这是提供承诺,
对抗日益增长的抗药性病原体的威胁。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joshua Modell其他文献
Joshua Modell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joshua Modell', 18)}}的其他基金
Non-canonical functions of Cas9 andthe cell biology of CRISPR-Cas immunity
Cas9的非典型功能和CRISPR-Cas免疫的细胞生物学
- 批准号:
10797054 - 财政年份:2021
- 资助金额:
$ 40.94万 - 项目类别:
Non-canonical functions of Cas9 andthe cell biology of CRISPR-Cas immunity
Cas9的非典型功能和CRISPR-Cas免疫的细胞生物学
- 批准号:
10275091 - 财政年份:2021
- 资助金额:
$ 40.94万 - 项目类别:
Non-canonical functions of Cas9 andthe cell biology of CRISPR-Cas immunity
Cas9的非典型功能和CRISPR-Cas免疫的细胞生物学
- 批准号:
10648318 - 财政年份:2021
- 资助金额:
$ 40.94万 - 项目类别:
Non-canonical functions of Cas9 andthe cell biology of CRISPR-Cas immunity
Cas9的非典型功能和CRISPR-Cas免疫的细胞生物学
- 批准号:
10618312 - 财政年份:2021
- 资助金额:
$ 40.94万 - 项目类别:
Non-canonical functions of Cas9 andthe cell biology of CRISPR-Cas immunity
Cas9的非典型功能和CRISPR-Cas免疫的细胞生物学
- 批准号:
10806683 - 财政年份:2021
- 资助金额:
$ 40.94万 - 项目类别:
相似海外基金
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 40.94万 - 项目类别:
B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
- 批准号:
MR/Y033701/1 - 财政年份:2024
- 资助金额:
$ 40.94万 - 项目类别:
Research Grant
Applying advanced understanding of CTLA-4 function to optimise therapies for autoimmunity
应用对 CTLA-4 功能的深入理解来优化自身免疫疗法
- 批准号:
MR/Y001273/1 - 财政年份:2024
- 资助金额:
$ 40.94万 - 项目类别:
Research Grant
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
MUC16 (CA125) 突变促进系统性硬化症的纤维化和自身免疫
- 批准号:
478933 - 财政年份:2023
- 资助金额:
$ 40.94万 - 项目类别:
Operating Grants
Development of serologic test for early risk stratification of islet autoimmunity in genetically predisposed T1D individuals
开发用于遗传易感性 T1D 个体胰岛自身免疫早期风险分层的血清学检测
- 批准号:
10760885 - 财政年份:2023
- 资助金额:
$ 40.94万 - 项目类别:
Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA)
新发自身免疫/纵向免疫系统分析(MONA-LISA)的机制
- 批准号:
10655219 - 财政年份:2023
- 资助金额:
$ 40.94万 - 项目类别:
Autoimmunity-Associated B Cells in Lupus Nephritis
狼疮性肾炎中自身免疫相关的 B 细胞
- 批准号:
10582053 - 财政年份:2023
- 资助金额:
$ 40.94万 - 项目类别:
Heparan sulfate as a platform to boost regulatory T cell suppression of autoimmunity
硫酸乙酰肝素作为增强调节性 T 细胞抑制自身免疫的平台
- 批准号:
490663 - 财政年份:2023
- 资助金额:
$ 40.94万 - 项目类别:
Operating Grants
The interplay of sex hormones and chromosomes dictates pathogenicity in progressive CNS autoimmunity.
性激素和染色体的相互作用决定了进行性中枢神经系统自身免疫的致病性。
- 批准号:
488982 - 财政年份:2023
- 资助金额:
$ 40.94万 - 项目类别:
Operating Grants
Understanding autoimmunity: Why do B cells sometimes attack our tissues instead of protecting us from infections?
了解自身免疫:为什么 B 细胞有时会攻击我们的组织而不是保护我们免受感染?
- 批准号:
2889164 - 财政年份:2023
- 资助金额:
$ 40.94万 - 项目类别:
Studentship